Safety Profile Holds Key to Triumph of Edoxaban: Daiichi Sankyo President

President and CEO Joji Nakayama Daiichi Sankyo President and CEO Joji Nakayama believes that the safety profile will be the key to the success of the anticoagulant edoxaban (brand name in Japan: Lixiana), which is hoped to thrive as the...read more